2022
DOI: 10.1136/bcr-2021-247040
|View full text |Cite
|
Sign up to set email alerts
|

Multisystem organ failure secondary to acute generalised exanthematous pustulosis (AGEP) with atypical presentation resembling septic shock

Abstract: A woman was admitted for sepsis secondary to cellulitis. After clinical improvement of sepsis, non-follicular small pustules were observed on the trunk, limbs and face while vesicles/bullae and skin exfoliation were noted on upper extremities. Larger systemic manifestations included fever, hypertension and tachycardia. Laboratory results revealed neutrophilic leukocytosis, eosinophilia, mild transaminitis and acute renal failure. Despite treatment for potential sepsis and discontinuation of offending agents, h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…In order to accurately assess AGEP-associated mortality, more research is needed to relate death events to follow-up periods, severity, treatment, and comorbidities. AGEP may, rarely, be followed by long-term complications in the event of multiorgan involvement, such as kidney damage, but this is rare and atypical and may resolve with the use of systemic corticosteroids [ 223 ]. It is important to note that AGEP can recur after reintroduction of the causative drug or trigger [ 23 , 224 ].…”
Section: Clinical Prognosis and Long-term Outcomesmentioning
confidence: 99%
“…In order to accurately assess AGEP-associated mortality, more research is needed to relate death events to follow-up periods, severity, treatment, and comorbidities. AGEP may, rarely, be followed by long-term complications in the event of multiorgan involvement, such as kidney damage, but this is rare and atypical and may resolve with the use of systemic corticosteroids [ 223 ]. It is important to note that AGEP can recur after reintroduction of the causative drug or trigger [ 23 , 224 ].…”
Section: Clinical Prognosis and Long-term Outcomesmentioning
confidence: 99%